Aldeyra Therapeutics, Inc. provides medical services. The Company deals in treatment and research for dry eye disease, allergic conjunctivitis, and other forms of ocular inflammation. Aldeyra Therapeutics serves patients in the United States.

Current Report (Form 8-K | Period ending 2025-11-13)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aldeyra Therapeutics (ALDX US)

Current Report (Form 8-K | Period ending 2025-11-13)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Current Report (Form 8-K | Period ending 2025-10-28)

Current Report (Form 8-K | Period ending 2025-08-19)

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)